Ilika Plc · LSE:IKA
Ilika — Investor Day (May 2025)
22 slides from Ilika's investor day presentation, May 2025
Slide 1: isla
isla fio fle jw =a dyin fe vo feioiis eye etsy
Slide 2: Capital Markets Day May 2025
Capital Markets Day May 2025
Slide 3: Disclaimer
Disclaimer THIS PRESENTATION AND ITS CONTENTS ARE CONFIDENTIAL AND ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION WHE
Slide 4: Introduction to Management Team
Introduction to Management Team Board and Management Team Offers a Wealth of Diversified Experience Across Multiple Industries Graeme Purdy Jason Stewart Keith Jackson Jeremy Millard Monika Biddulph Louise Turner John Tinson Chief Executive Officer Chief Financial Officer Non-exec Chairman Non-Execu
Slide 5: Ilika at a Glance: leading solid state battery developer
Ilika at a Glance: leading solid state battery developer Stereax – licensed to Cirtec Goliath – MVP due CY26 Miniature cells used primarily to Large format cells targeting the power miniature medical devices and automotive industry and cordless industrial IoT consumer appliances Manufacturing partne
Slide 6: Ilika: Delivering Commercial Milestones
Ilika: Delivering Commercial Milestones Stereax equipment Completion of Commencement of Commencement of commissioning engineering lots at M300 product customer product completed at Cirtec Cirtec validation programme delivery H2 2025 H1 2025 Release of P1.5 Release P2 D8 50Ah capacity P1 prototype ev
Slide 7: Ilika Business Model
Ilika Business Model Asset-light licensing model demonstrated on production-intent equipment Battery and assembly supply IP defining materials, IP defining materials, batteries and process batteries and process Manufacturing Development battery sales partners sell OEM partners product to sell produc
Slide 8: Stereax: Global Healthcare Trends & Market Demand
Stereax: Global Healthcare Trends & Market Demand The use of smart electronic Market Demand driven by innovation in Active Implantable Medical Devices electroceuticals and sensors (AIMD) is at the forefront of a search for efficacy and productivity Orthopedics $27.3Bn (2023) CAGR: 4.2% ▪ Data captur
Slide 9: Stereax: An Enabling Technology
Stereax: An Enabling Technology First Product Stereax M300 Stereax benefits: ▪ Rechargeable ▪ Reduced surgery time ▪ Voltage: 3.5V ▪ Implant located close to point of therapy ▪ Capacity: 300 µAh ▪ Long life in the body ▪ Max pulse current: 3 mA (10C) ▪ User recharge at home ▪ Cycle life: >1000 cycle
Slide 10: Stereax: Partnership for Growth
Stereax: Partnership for Growth 6 Cirtec is a leading global provider of outsourced End Uses medical device and components design, engineering and manufacturing 21 Customers 24 Orders 10-year licence & manufacturing Commercial revenues via wafer processing agreement signed August 2023 income in FY26
Slide 11: Stereax: Applications (1)
Stereax: Applications (1) • Current neurostimulators use large batteries • Miniaturised neurostimulators with Stereax • Can only be implanted in chest or buttocks batteries can be implanted near the target organ (here Vagus nerve) Overview Stereax Goliath Summary 11 11
Slide 12: Stereax: Applications (2)
Stereax: Applications (2) Smart orthopedics Smart orthodontic Cardiac sensors Smart ophthalmics Overview Stereax Goliath Summary 12 12
Slide 13: Brad Womble Video – Cirtec Medical
Brad Womble Video – Cirtec Medical 13
Slide 14: Stereax: Licensing Coming Onstream
Stereax: Licensing Coming Onstream Cumulative revenue from Stereax product lines ▪ Income growth derived from Indicative Cumulative multiple revenue streams Revenue ▪ Royalty timelines driven by the certification of medical devices ▪ Industrial IoT addressable at larger volumes Wafer Processing Non-
Slide 15: Goliath: Enabling further EV sector growth
Goliath: Enabling further EV sector growth Record Electric Vehicles Reasons for not purchasing Sales in 2024 1 an Electric Vehicle 2 18 16 14 Recharging Time 42% Electric Vehicles Sales / Millions 12 10 8 Driving Range 36% 6 4 2 Risk of Battery Fires 21% 0 2020 2021 2022 2023 2024 China Europe Unite
Slide 16: Goliath: Technology Benefits Validated
Goliath: Technology Benefits Validated SSB benefits to OEMs & suppliers Lower Faster Longer cell Enhanced Lower pack production charging life safety weight cost times UK Pack Designers Balance Batteries modelled a hypothetical Hyundai Ioniq 5 pack with Goliath - £2,500 - 6 min Cost effective Weight
Slide 17: Goliath: Ilika's Cutting Edge Solid State EV Battery
Goliath: Ilika’s Cutting Edge Solid State EV Battery EUCAR 6 EUCAR 3 Goliath delivers a safer, lower temperature response without flames to mechanical pouch penetration and shorting. Overview Stereax Goliath Summary 17
Slide 18: Goliath: Scale-up De-risked at UKBIC
Goliath: Scale-up De-risked at UKBIC UKBIC Deliverables: Impact for Goliath: ▪ Successful coating of electrode- ▪ Standardised gigafactory industrial electrolyte composite equipment can be used ▪ Higher manufacturing yield ▪ Reduced manufacturing CAPEX ▪ Higher capacity batteries under faster requir
Slide 19: Bridging the Gap: What to Expect
Bridging the Gap: What to Expect D4 design freeze, 1st Gen D5 delivered with exemplary D8 50Ah capacity reached customer prototypes safety data P1.5 2nd Gen customer Li-ion density parity P1 prototype released to prototypes to be achieved customers released D6 10Ah 1.5MWh assembly capacity line inst
Slide 20: Goliath: Ilika Scale-up Plan and Business Model
Goliath: Ilika Scale-up Plan and Business Model Overview Stereax Goliath Summary 20
Slide 21: Goliath: Commercial Traction & Indicative Revenue Build Up
Goliath: Commercial Traction & Indicative Revenue Build Up Revenue from Goliath product lines 4 Applications Cumulative Revenue 21 Customers 8 EU Customers 2026 Non Reccurring Battery Royalty Licence Issuance Grant Income Revenue Engineering Fee Overview Stereax Goliath Summary 21
Slide 22: Summarising our Investment Case
Summarising our Investment Case Solid-state battery technology; growing patented portfolio across multiple jurisdictions Diversified across two markets with near-term route to commercialisation, reducing execution risk In-house, purpose built, fabrication facilities and partnerships drive and valida